Can a med spa in Ohio offer compounded semaglutide or tirzepatide?
Facility · part of The Practice Perimeter
Short answer
Not on the prescriber exemption alone — possessing compounded semaglutide requires a terminal distributor of dangerous drugs license, and a pharmacy may compound for office use only if the drug is not commercially available, in limited quantity, occasionally.
⚠️ Ohio does license the premises — just not through the medical board. a manufacturer, outsourcing facility, third-party logistics provider, repackager or wholesale distributor may sell or distribute dangerous drugs only to a licensed terminal distributor of dangerous drugs, or to a person exempt from that licensure under § 4729.541. Whether a med spa may take delivery of a drug at all turns on which of those two it is.
Ohio Rev. Code § 4729.51(B) · verified Sep 2, 2026 · regulatory monitoring, not legal advice
Related Ohio rules
⚠️ and then the exemption evaporates the moment the drug is compounded. Any of those otherwise-exempt persons “shall hold a license as a terminal distributor of dangerous drugs in order to possess, have custody or control of, and distribute” (1) “dangerous drugs that are compounded or used for the purpose of compounding” and (2) any schedule I to V controlled substance. An Ohio practice holding compounded semaglutide — or testosterone — needs the license its prescribers would otherwise not have needed.
Ohio Rev. Code § 4729.541(C) · verified Sep 2, 2026
Ohio’s office-use compounding route exists and carries three conditions that must all hold. a pharmacy may compound at a prescriber’s request for a drug “to be used by the professional for the purpose of direct administration to patients in the course of the professional’s practice” only if: (a) “at the time the request is made, the drug is not commercially available regardless of the reason”, including a manufacturer’s absence or lack of readily available supply; (b) “a limited quantity” is compounded and provided; and (c) it is done “as an occasional exception to the normal practice of dispensing drugs pursuant to patient-specific prescriptions”. ⚠️ commercial availability is the switch — when the branded drug can be had, this route closes.
Ohio Rev. Code § 4729.01(C)(5) · verified Sep 2, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Related Ohio questions
- Is an exam required before a patient can be treated in Ohio?
- Can the pre-treatment exam be done by telehealth in Ohio?
- Must someone be on site while a patient is treated in Ohio?
Get Ohio changes as they publish
We scan the Ohio legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Ohio rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).